CFG
BSX icon

Cambridge Financial Group’s Boston Scientific BSX Stock Holding History

Cambridge Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-506,160
Closed -$6.46M – 32
2014
Q2 		$6.46M Sell
506,160
-12,466
-2% -$162K 3.21% 21
2014
Q1 		$7.01M Sell
518,626
-13,927
-3% -$183K 3.57% 8
2013
Q4 		$6.4M Sell
532,553
-82,797
-13% -$978K 3.26% 16
2013
Q3 		$7.22M Sell
615,350
-45,979
-7% -$497K 3.98% 1
2013
Q2 		$7.22M Buy
+661,329
New +$5.61M 3.64% 5

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cambridge Financial Group's BSX Position: Q3 2014 in Review

Cambridge Financial Group sold out of Boston Scientific (BSX) in Q3 2014, closing a stake of 506,160 shares — an estimated $6.46M sold.

Cambridge Financial Group first reported a position in BSX in Q2 2013 and held it in 5 quarters. The position peaked at $7.22M in Q3 2013. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

  • Cambridge Financial Group reported no remaining Boston Scientific position as of Q3 2014 after selling out during the quarter.
  • Cambridge Financial Group sold 506,160 Boston Scientific shares in Q3 2014, an estimated $6.46M.
  • Cambridge Financial Group first reported a position in Boston Scientific in Q2 2013 and held it in 5 quarters.
  • Cambridge Financial Group's Boston Scientific position peaked at $7.22M in Q3 2013.
  • 437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on Cambridge Financial Group's 13F filing for Q3 2014, filed 21 Oct 2014.